Referências
Principais artigos
Gertz MA. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017 Feb;92(2):209-17.Texto completo Resumo
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90.Texto completo Resumo
Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.Texto completo Resumo
Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.Texto completo Resumo
Artigos de referência
1. Lichtin AE, Cook JR. Diseases of the spleen. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:697-705.
2. McKenzie CV, Colonne CK, Yeo JH, et al. Splenomegaly: pathophysiological bases and therapeutic options. Int J Biochem Cell Biol. 2017 Dec 2;94:40-3. Resumo
3. Sjoberg BP, Menias CO, Lubner MG, et al. Splenomegaly: a combined clinical and radiologic approach to the differential diagnosis. Gastroenterol Clin North Am. 2018 Sep;47(3):643-66. Resumo
4. Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005 May;21(3):323-30. Resumo
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: chronic lymphocytic leukemia/small lymphocytic lymphoma [internet publication].Texto completo
6. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas [internet publication].Texto completo
7. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hodgkin lymphoma [internet publication]Texto completo
8. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long term follow-up of no initial therapy. J Clin Oncol. 2004 Apr 15;22(8):1454-9.Texto completo Resumo
9. Koc O, Wilson WH. Non-Hodgkin's lymphoma. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:579-95.
10. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004 Nov 15;104(10):3009-20.Texto completo Resumo
11. Gavriatopoulou M, Musto P, Caers J, et al. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018 Sep;32(9):1883-98. Resumo
12. Gertz MA. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017 Feb;92(2):209-17.Texto completo Resumo
13. Frater JL. T-cell prolymphocytic leukemia: review of an entity and its differential diagnostic considerations. Int J Lab Hematol. 2020 Jun;42 Suppl 1:90-8. Resumo
14. Licata MJ, Janakiram M, Tan S, et al. Diagnostic challenges of adult T-cell leukemia/lymphoma in North America - a clinical, histological, and immunophenotypic correlation with a workflow proposal. Leuk Lymphoma. 2018 May;59(5):1188-94. Resumo
15. Kutok JL, Fletcher CD. Splenic vascular tumors. Semin Diagn Pathol. 2003 May;20(2):128-39. Resumo
16. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90.Texto completo Resumo
17. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hairy cell leukemia [internet publication].Texto completo
18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: myeloproliferative neoplasms [internet publication].Texto completo
19. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: acute lymphoblastic leukemia [internet publication].Texto completo
20. Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008 Aug 7;359(6):575-83.Texto completo Resumo
21. Cortes JE, Talpaz M, O'Brien S, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006 Mar 15;106(6):1306-15. Resumo
22. Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology. 2004 Jun;18(7):837-44. Resumo
23. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000 Apr 27;342(17):1255-65. Resumo
24. Tefferi A, Rumi E, Finazzi G, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia. 2013 Sep;27(9):1874-81.Texto completo Resumo
25. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2361-71.Texto completo Resumo
26. Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020 Apr 16;135(16):1332-43.Texto completo Resumo
27. Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2015;2015:177-82.Texto completo Resumo
28. Jordan MB, Allen CE, Greenberg J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019 Nov;66(11):e27929.Texto completo Resumo
29. La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019 Jun 6;133(23):2465-77.Texto completo Resumo
30. Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.Texto completo Resumo
31. Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20. Resumo
32. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007 Feb;48(2):124-31. Resumo
33. Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr. 2005 Aug;17(4):519-24. Resumo
34. Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis. 2002 Oct;25(6):491-500. Resumo
35. World Health Organization. WHO Guidelines for malaria. Mar 2023 [internet publication].Texto completo
36. Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States: a systematic review. JAMA. 2007 May 23;297(20):2264-77. Resumo
37. Leoni S, Buonfrate D, Angheben A, et al. The hyper-reactive malarial splenomegaly: a systematic review of the literature. Malar J. 2015 Apr 29;14:185.Texto completo Resumo
38. Kan FK, Tan CC, Von Bahr Greenwood T, et al. Dengue infection complicated by hemophagocytic lymphohistiocytosis: experiences from 180 patients with severe dengue. Clin Infect Dis. 2020 May 23;70(11):2247-55.Texto completo Resumo
39. Giang HTN, Banno K, Minh LHN, et al. Dengue hemophagocytic syndrome: a systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors. Rev Med Virol. 2018 Nov;28(6):e2005. Resumo
40. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008 Nov 15;112(10):3939-48.Texto completo Resumo
41. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008 Nov 15;112(10):3927-38.Texto completo Resumo
42. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006 May 11;354(19):2034-45. Resumo
43. Shmueli H, Flint N, Pollick C, et al. Spleen size and appearance by transesophageal echocardiography in patients with suspected infective endocarditis. JACC Cardiovasc Imaging. 2020 Apr;13(4):1082-3.Texto completo Resumo
44. Yung L, Linch D. Hodgkin's lymphoma. Lancet. 2003 Mar 15;361(9361):943-51. Resumo
45. Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Jul 30;108(9):1400-15.Texto completo Resumo
46. American Society for Clinical Pathology. Choosing wisely: testing for amylase. Sep 2016 [internet publication].Texto completo
47. Cessford T, Meneilly GS, Arishenkoff S, et al. Comparing physical examination with sonographic versions of the same examination techniques for splenomegaly. J Ultrasound Med. 2018 Jul;37(7):1621-9. Resumo
48. Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: review of techniques and clinical applications. Theranostics. 2017;7(5):1303-29.Texto completo Resumo
49. Gary SE, Ryan E, Steward AM, et al. Recent advances in the diagnosis and management of Gaucher disease. Expert Rev Endocrinol Metab. 2018 Mar;13(2):107-18.Texto completo Resumo
50. Batur A, Alagoz S, Durmaz F, et al. Measurement of spleen stiffness by shear-wave elastography for prediction of splenomegaly etiology. Ultrasound Q. 2019 Jun;35(2):153-6. Resumo
51. İmamoğlu H, Zararsız G, Özdemir M, et al. The orthogonal measurements approach in estimating spleen size on CT images. Diagn Interv Radiol. 2020 Jan;26(1):5-10.Texto completo Resumo
52. Indiran V, Vinod Singh N, Ramachandra Prasad T, et al. Does coronal oblique length of spleen on CT reflect splenic index? Abdom Radiol (NY). 2017 May;42(5):1444-8. Resumo
53. Kucybała I, Ciuk S, Tęczar J. Spleen enlargement assessment using computed tomography: which coefficient correlates the strongest with the real volume of the spleen? Abdom Radiol (NY). 2018 Sep;43(9):2455-61.Texto completo Resumo
54. Gunes SO, Akturk Y. Determination of splenomegaly by coronal oblique length on CT. Jpn J Radiol. 2018 Feb;36(2):142-50. Resumo
55. Huo Y, Liu J, Xu Z, et al. Robust multicontrast MRI spleen segmentation for splenomegaly using multi-atlas segmentation. IEEE Trans Biomed Eng. 2018 Feb;65(2):336-43.Texto completo Resumo
56. Huo Y, Xu Z, Bao S, et al. Splenomegaly segmentation on multi-modal MRI using deep convolutional networks. IEEE Trans Med Imaging. 2019 May;38(5):1185-96.Texto completo Resumo
57. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2019 Jan;94(1):133-43.Texto completo Resumo
58. Cetin G, Ozkan T, Turgut S, et al. Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. Mol Biol Rep. 2014 Oct;41(10):6737-42. Resumo
59. Karaköse S, Oruç N, Zengin M, et al. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis. Turk J Gastroenterol. 2015 Jan;26(1):42-8.Texto completo Resumo
60. Thurmes PJ, Steensma DP. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis. Eur J Haematol. 2006 Jul;77(1):57-60. Resumo
61. Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 Nov 6;69(1):394-419.Texto completo Resumo
62. Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019 Aug;68(8):1356-78.Texto completo Resumo
63. Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.Texto completo Resumo
64. Mehta A, Kuter DJ, Salek SS, et al. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Intern Med J. 2019 May;49(5):578-91.Texto completo Resumo
65. Deshwal R. Clinical and laboratory profile of hospitalized malarial patients: an Agra-based study. J Assoc Physicians India. 2016 Aug;64(8):44-7.Texto completo Resumo
66. Guo C, Zhou Z, Wen Z, et al. Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017;7:317.Texto completo Resumo
67. World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Oct 2009 [internet publication].Texto completo
68. Ferreira BDC, Correia D. Ultrasound assessment of hepatobiliary and splenic changes in patients with dengue and warning signs during the acute and recovery phases. J Ultrasound Med. 2019 Aug;38(8):2015-24. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal